“…Its role in apoptosis supports this hypothesis (Zamzami and Kroemer, 2001) and it was shown that mtDNA mutations may lead to a dysregulation of oxidative phosphorylation that can enhance production of the carcinogenic ROS. Over last years, somatic mtDNA mutations have been reported in many human tumours (Polyak et al, 1998;Maximo et al, 2000;Richard et al, 2000;Yeh et al, 2000;Hibi et al, 2001b;Sanchez-Cespedes et al, 2001;Kirches et al, 2001;Liu et al, 2001;Lievre et al, 2005), including head and neck squamous cell carcinoma (HNSCC) that were found mutated in small series in 37 -77% of the cases (Fliss et al, 2000;Sanchez-Cespedes et al, 2001;Ha et al, 2002;Tan et al, 2003;Poetsch et al, 2004). Although mutations may occur throughout the mitochondrial genome, the vast majority of them have been described in the noncoding region of the D-Loop and particularly in a mononucleotide repeat named D310 (C-tract, nucleotide position: 303 -315) that has emerged as a mutational hotspot in HNSCC (Fliss et al, 2000;Sanchez-Cespedes et al, 2001;Ha et al, 2002;Tan et al, 2003;Poetsch et al, 2004).…”